Anna D. Grabowska

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis

C. Scheibenbogen, E. Lacerda, L. Graça, 2022, Frontiers in Medicine.

Translation of a Leaderless Reporter Is Robust During Exponential Growth and Well Sustained During Stress Conditions in Mycobacterium tuberculosis

N. Andreu, T. Cortes, A. Grabowska, 2021, Frontiers in Microbiology.

Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood–Brain Barrier and the Risk of Dementia

M. Wątroba, D. Szukiewicz, M. Watroba, 2023, International journal of molecular sciences.

Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation

M. Wątroba, D. Szukiewicz, N. Sepúlveda, 2023, International journal of molecular sciences.

The Role of Glucose Concentration and Resveratrol in Modulating Neuroinflammatory Cytokines: Insights from an In Vitro Blood–Brain Barrier Model

M. Wątroba, D. Szukiewicz, M. Watroba, 2023, Medical science monitor : international medical journal of experimental and clinical research.

Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis

C. Scheibenbogen, E. Lacerda, J. Ameijeiras-Alonso, 2023, Heliyon.

Anti-Inflammatory Action of Resveratrol in the Central Nervous System in Relation to Glucose Concentration—An In Vitro Study on a Blood–Brain Barrier Model

M. Wątroba, D. Szukiewicz, Anna D. Grabowska, 2024, International journal of molecular sciences.

Anti-inammatory action of resveratrol in the central nervous system in relation to glucose concentration - an in vitro study on a blood-brain barrier model

M. Wątroba, Anna D. Grabowska, Justyna Komorowska, 2022 .

The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID

E. Lacerda, L. Nacul, N. Sepúlveda, 2023, Frontiers in public health.

Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy

M. Wątroba, D. Szukiewicz, Anna D. Grabowska, 2024, International journal of molecular sciences.